Toxicon
Revista
Teléfono
-
- Visión general
-
- Otro
-
- Ver todos
-
Visión general
Lugar de publicación
-
Snakebite envenoming in French Guiana: Assessment of the preclinical efficacy against the venom of Bothrops atrox of two polyspecific antivenoms.
173:1-4.
2020
-
A functional role for snake envenomation wound exudate in local and systemically observed pathophysiology.
158:S1.
2019
-
An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action.
130:885-901.
2019
-
Antivenom against Vipera berus is effective against Macrovipera lebetina.
159:S32.
2019
-
Cocktails of human monoclonal IgG antibodies capable of neutralizing dendrotoxin-mediated neurotoxicity of black mamba venom in vivo.
159:S5-S6.
2019
-
Effect of premedication with subcutaneous adrenaline on the pharmacokinetics and immunogenicity of equine whole IgG antivenom in a rabbit model.
159:S17-S18.
2019
-
Escuela de Educación Física y Deportes, UCR.
159:61-62.
2019
-
Harnessing human monoclonal antibodies for neutralisation of dendrotoxins in a murine model.
159:S14.
2019
-
Harnessing phage display technology for discovery of human IgGs targeting clinically relevant toxins from the venom of the Central American coral snake (Micrurus nigrocinctus).
158:S45.
2019
-
Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: Comparative characterization and synergism between Asp49 and Lys49 variants.
168:113-121.
2019
-
Local and systemic pathophysiological alterations induced by a serine proteinase from the venom of the snake Bothrops jararacussu.
18:1063-1069.
2019
-
Monoclonal human IgGs capable of neutralizing elapid neurotoxins in vivo.
158:S44.
2019
-
Nephrotoxicity induced by the venom of Hypnale hypnale from Sri Lanka: Studies on isolated perfused rat kidney and renal tubular cell lines.
165:40-46.
2019
-
Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2.
157:1-7.
2019
-
Structural analysis of a myotoxin-antimyotoxin complex by cross-linking, mass spectrometry, and bioinformatics.
158:S29-S30.
2019
-
Three-finger toxins from the venom of Micrurus tschudii tschudii (desert coral snake): Isolation and characterization of tschuditoxin-I.
167:144-151.
2019
-
Venom characterization of the bark scorpion Centruroides edwardsii (Gervais 1843): Composition, biochemical activities and in vivo toxicity for potential prey.
171:7-19.
2019
-
A myotoxic Lys49 phospholipase A 2 -homologue is the major component of the venom of Bothrops cotiara from Misiones, Argentina.
148:143-148.
2018
-
Analgesic effect of morphine and tramadol in standard toxicity assays in mice injected with venom of the snake Bothrops asper.
154:35-41.
2018
-
Antivenoms: Life-saving drugs for envenomings by animal bites and stings.
150:11-12.
2018
-
Bornyl cinnamate derivatives with anti-inflammatory activity from Verbesina turbacensis.
10:115-118.
2018
-
Contributions of the snake venoms of Bothrops asper, Crotalus simus and Lachesis stenophrys to the paraspecificity of the Central American polyspecific antivenom (PoliVal-ICP).
144:1-6.
2018
-
Current technology for the industrial manufacture of snake antivenoms.
151:63-73.
2018
-
Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom.
10:380-781.
2018
-
Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: Pharmacological mediation and molecular determinants.
41:667-678.
2018
-
Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom.
23:807-813.
2018
-
Light Emitting Diode (LED) therapy reduces local pathological changes induced by Bothrops asper snake venom.
152:95-102.
2018
-
Olivo, Renata do A..
146:87-90.
2018
-
Preclinical assessment of the neutralizing efficacy of antivenoms in Latin America and the Caribbean: A review.
146:138-150.
2018
-
Preclinical evaluation of the neutralizing ability of a monospecific antivenom for the treatment of envenomings by Bothrops lanceolatus in Martinique.
148:50-55.
2018
-
Pros and cons of different therapeutic antibody formats for recombinant antivenom development.
146:151-175.
2018
-
Proteomic studies on Micrurus (coral snakes) venom reveal a dichotomy of phenotypes.
150:319-320.
2018
-
Robust PI/PID controllers for load disturbance based on direct synthesis.
59:158-162.
2018
-
Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms.
148:123-131.
2018
-
Venom gland transcriptomics and microRNA profiling of juvenile and adult yellow-bellied sea snake, Hydrophis platurus, from Playa del Coco (Guanacaste, Costa Rica).
153:96-105.
2018
-
Pitfalls to avoid when using phage display for snake toxins.
121:79-89.
2017
-
Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: Comparison of high- and low-molecular weight fractions.
51:373-380.
2017
-
An improved technique for the assessment of venom-induced haemorrhage in a murine model.
139:87-93.
2017
-
Assessing survival of wild-caught snakes in open venom production systems.
138:49-52.
2017
-
Comparison of biochemical and cytotoxic activities of extracts obtained from dorsal spines and caudal fin of adult and juvenile non-native Caribbean lionfish (Pterois volitans/miles).
137:158-167.
2017
-
Comparison of the adjuvant activity of emulsions with different physicochemical properties on the antibody response towards the venom of West African carpet viper (Echis ocellatus).
127:106-111.
2017
-
Cross-reactivity and cross-immunomodulation between venoms of the snakes Bothrops asper , Crotalus simus and Lachesis stenophrys , and its effect in the production of polyspecific antivenom for Central America.
138:43-48.
2017
-
Danger in the reef: Proteome, toxicity, and neutralization of the venom of the olive sea snake, Aipysurus laevis.
107:187-196.
2017
-
Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa.
125:59-64.
2017
-
Freeze-dried EchiTAb+ICP antivenom formulated with sucrose is more resistant to thermal stress than the liquid formulation stabilized with sorbitol.
133:123-126.
2017
-
Geographical variability of the venoms of four populations of Bothrops asper from Panama: Toxicological analysis and neutralization by a polyvalent antivenom.
132:55-61.
2017
-
High-density peptide microarray exploration of the antibody response in a rabbit immunized with a neurotoxic venom fraction.
138:151-158.
2017
-
Identification of B cell recognized linear epitopes in a snake venom serine proteinase from the central American bushmaster Lachesis stenophrys.
140:72-82.
2017
-
Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom.
135:40-49.
2017
-
Physicochemical characterization of commercial freeze-dried snake antivenoms.
126:32-37.
2017
-
Divergent functional profiles of acidic and basic phospholipases A2 in the venom of the snake Porthidium lansbergii lansbergii.
119:289-298.
2016
-
A polyspecific antivenom for Sri Lanka: First to include Hypnale.
117:103.
2016
-
Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region.
45:807-815.
2016
-
De León Castrejón, Tirza.
109:51-62.
2016
-
Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom.
120:1-8.
2016
-
Development of a new polyspecific antivenom for snakebite envenoming in Sri Lanka: Analysis of its preclinical efficacy as compared to a currently available antivenom.
122:152-159.
2016
-
Journal of Herpetology.
119:171-179.
2016
-
Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
119:280-288.
2016
-
Venoms of Micrurus coral snakes: Evolutionary trends in compositional patterns emerging from proteomic analyses.
122:7-25.
2016
-
Effect of geographical variation of Echis ocellatus, Naja nigricollis and Bitis arietans venoms on their neutralization by homologous and heterologous antivenoms.
108:80-83.
2015
-
Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins.
99:23-35.
2015
-
A Lys49 phospholipase A2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line.
45:651-660.
2015
-
A bright future for integrative venomics.
107:159-162.
2015
-
Assessing endotoxins in equine-derived snake antivenoms: Comparison of the USP pyrogen test and the Limulus Amoebocyte Lysate assay (LAL).
105:13-18.
2015
-
Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms.
42:307-312.
2015
-
Efectos locales inducidos por el veneno de la serpiente coral Micrurus nigrocinctus en ratón blanco.
18:633-639.
2015
-
Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria.
106:97-107.
2015
-
First crotoxin-like phospholipase A2 complex from a New World non-rattlesnake species: Nigroviriditoxin, from the arboreal Neotropical snake Bothriechis nigroviridis.
93:144-154.
2015
-
Lachesis stenophrys venom reduces the equine antibody response towards Bothrops asper venom used as co-immunogen in the production of polyspecific snake antivenom.
103:99-105.
2015
-
Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score.
104:43-45.
2015
-
Snake venomics of Micrurus alleni and Micrurus mosquitensis from the Caribbean region of Costa Rica reveals two divergent compositional patterns in New World elapids.
107:217-233.
2015
-
The multigene families of actinoporins (Part I): Isoforms and genetic structure..
103:176-187.
2015
-
Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: Identification of directly hemolytic phospholipases A2.
90:26-35.
2014
-
Proteomic and toxicological profiling of the venom of Bothrocophias campbelli, a pitviper species from Ecuador and Colombia.
90:15-25.
2014
-
A neutralizing recombinant single chain antibody, scFv, against BaP1, A P-I hemorrhagic metalloproteinase from Bothrops asper snake venom.
87:81-91.
2014
-
An electrophoretic study on phospholipase A2 isoenzymes in the venoms of Central American crotaline snakes.
30:815-823.
2014
-
Enlace al artículo.
46:806-813.
2014
-
Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: Comparison of their stability in an accelerated test.
90:56-63.
2014
-
Production in E. coli, folding, purification and characterization of notexin with wild type sequence and with N-terminal and catalityc site mutations..
88:11-20.
2014
-
The analgesics morphine and tramadol do not alter the acute toxicity induced by Bothrops asper snake venom in mice.
81:54-57.
2014
-
The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: Pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay.
93:41-50.
2014
-
Toxicity of Bothrops sp snake venoms from Ecuador and preclinical assessment of the neutralizing efficacy of a polyspecific antivenom from Costa Rica.
88:34-37.
2014
-
Amino acid sequence and biological characterization of BlatPLA2, a non-toxic acidic phospholipase A2 from the venom of the arboreal snake Bothriechis lateralis from Costa Rica.
73:71-80.
2013
-
Antivenom for snakebite envenoming in Sri Lanka: The need for geographically specific antivenom and improved efficacy.
69:90-97.
2013
-
Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics.
69:168-179.
2013
-
Biochemical and biological characterization of two serine proteinases from Colombian Crotalus durissus cumanensis snake venom.
63:32-43.
2013
-
Comparison of venom composition and biological activities of the subspecies Crotalus lepidus lepidus, Crotalus lepidus klauberi and Crotalus lepidus morulus from Mexico.
71:84-95.
2013
-
Enlace al artículo.
33:1387-1391.
2013
-
Glycolic acid inhibits enzymatic, hemorrhagic and edema-inducing activities of BaP1, a P–I metalloproteinase from Bothrops asper snake venom: Insights from docking and molecular modeling.
71:41-48.
2013
-
Investigación y desarrollo en ciencias exactas y naturales.
64:60-69.
2013
-
Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms.
76:63-76.
2013
-
Phospholipases A2: Unveiling the secrets of a functionally versatile group of snake venom toxins.
18:27-39.
2013
-
Role of the animal model on the pharmacokinetics of equine-derived antivenoms.
70:9-14.
2013
-
Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model.
63:19-31.
2013
-
160. Role of SVMPs, Matrikines and TLR4 in Snake Venom Induced Edema and Inflammation.
60:177.
2012
-
192. Action of Venom Metalloproteinases on Basement Membranes: Pathogenesis of Hemorrhage and Blistering in Snakebite Envenomings.
60:194-194.
2012
-
210. Understanding the Preclinical Efficacy Profile of Antivenoms: From the Lethality Potency Assay to Antivenomics.
60:203.
2012
-
222. Molecular Mechanisms Involved in PGE2 Release Induced by the Snake Venom Metalloproteinase BaP1 in Synoviocytes.
60:209-209.
2012
-
Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
59:344-355.
2012
-
Identification of linear B-cell epitopes on myotoxin II, a Lys49 phospholipase A2 homologue from Bothrops asper snake venom.
60:782-790.
2012
-
Improving antivenom availability and accessibility: Science, technology, and beyond.
60:676-687.
2012
-
Isolation and biochemical, functional and structural characterization of a novel l-amino acid oxidase from Lachesis muta snake venom.
60:1263-1276.
2012
-
Mipartoxin-I, a novel three-finger toxin, is the major neurotoxic component in the venom of the redtail coral snake Micrurus mipartitus (Elapidae).
60:851-863.
2012
-
Second generation snake antivenomics: Comparing immunoaffinity and immunodepletion protocols.
60:688-699.
2012
-
Snake venom Lys49 myotoxins: From phospholipases A 2 to non-enzymatic membrane disruptors.
60:520-530.
2012
-
Snake venomics and toxicological profiling of the arboreal pitviper Bothriechis supraciliaris from Costa Rica.
59:592-599.
2012
-
Standardization of assays for testing the neutralizing ability of antivenoms.
28:1127-1129.
2012
-
The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: An intravital and electron microscopic study.
32:41-55.
2012
-
A phospholipase A2 from Bothrops asper snake venom activates neutrophils in culture: Expression of cyclooxygenase-2 and PGE2 biosynthesis.
57:288-296.
2011
-
Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
58:558-564.
2011
-
Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: Implications for the production of polyspecific snake antivenoms.
57:237-243.
2011
-
Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica.
38:1429-1441.
2011
-
Acute physiopathological effects of honeybee (Apis mellifera) envenoming by subcutaneous route in a mouse model.
56:1007-1017.
2010
-
Chemical modification of histidine and lysine residues of myotoxic phospholipases A2 isolated from Bothrops asper and Bothrops godmani snake venoms: Effects on enzymatic and pharmacological properties.
35:241-252.
2010
-
Consultorías en ciencias de la salud.
55:642-645.
2010
-
Docencia universitaria en pregrado en ingenierías y tecnologías.
56:1059-1065.
2010
-
Erratum to Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: Contributions to understanding snakebite envenomings and their treatment [Toxicon 54, 7, (2009), 1012-1028].
55:1412-1413.
2010
-
Isolation and biological characterization of Batx-I, a weak hemorrhagic and fibrinogenolytic PI metalloproteinase from Colombian Bothrops atrox venom.
56:936-943.
2010
-
Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP (R)) for the treatment of viper envenoming in sub-Saharan Africa.
55:369-374.
2010
-
Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms.
56:980-989.
2010
-
Snakebite envenoming from a global perspective: Towards an integrated approach.
56:1223-1235.
2010
-
The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes.
55:590-596.
2010
-
Tissue pathology induced by snake venoms: How to understand a complex pattern of alterations from a systems biology perspective?.
55:166-170.
2010
-
Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper.
54:949-957.
2009
-
Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom.
1:233-244.
2009
-
Experimental pathology of local tissue damage induced by Bothrops asper snake venom.
54:958-975.
2009
-
Experimental pathophysiology of systemic alterations induced by Bothrops asper snake venom.
54:976-987.
2009
-
Inflammation induced by Bothrops asper venom.
54:988-997.
2009
-
Investigación y desarrollo en ingenierías y tecnologías.
54:1012-1028.
2009
-
Natural history of the terciopelo Bothrops asper (Serpentes: Viperidae) in Costa Rica.
54:904-922.
2009
-
Phenotypic differences in a cryptic predator: Factors influencing morphological variation in the terciopelo Bothrops asper (Garman, 1884; Serpentes: Viperidae).
54:923-937.
2009
-
Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature.
53:609-615.
2009
-
Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: Report of a workshop.
53:625-630.
2009
-
Studies on the venom proteome of Bothrops asper: Perspectives and applications.
54:938-948.
2009
-
A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo).
27:589-596.
2008
-
Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom.
52:754-759.
2008
-
Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom.
52:302-308.
2008
-
Matchar, David B..
52:428-439.
2008
-
Mortality due to snakebite envenomation in Costa Rica (1993-2006).
52:530-533.
2008
-
Systemic and local myotoxicity induced by snake venom group II phospholipases A2: Comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue.
51:80-92.
2008
-
Cytotoxicity of Lachesis muta muta snake (bushmaster) venom and its purified basic phospholipase A2 (LmTX-I) in cultured cells.
49:678-692.
2007
-
Dissociation of enzymatic and toxic activities by the use of antibodies.
28:1245-1246.
2007
-
El centenario del nacimiento de Clodomiro Picado T. y el retorno del Mutacionismo.
35:1-4.
2007
-
Role of cyclooxygenases in oedema-forming activity of bothropic venoms.
49:670-677.
2007
-
Strengthening antivenom production in Central and South American public laboratories: Report of a workshop.
49:30-35.
2007
-
Calcium plays a key role in the effects induced by a snake venom Lys49 phospholipase A 2 homologue on a lymphoblastoid cell line.
47:75-86.
2006
-
Inflammatory effects of BaP1 a metalloproteinase isolated from Bothrops asper snake venom: Leukocyte recruitment and release of cytokines.
47:549-559.
2006
-
Pharmacokinetics of whole IgG equine antivenom: Comparison between normal and envenomed rabbits.
48:255-263.
2006
-
Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A2.
46:523-532.
2005
-
Anticomplementary activity of equine whole IgG antivenoms: Comparison of three fractionation protocols.
45:123-128.
2005
-
Hemorrhage induced by snake venom metalloproteinases: Biochemical and biophysical mechanisms involved in microvessel damage.
45:997-1011.
2005
-
Inflammatory events induced by Lys-49 and Asp-49 phospholipases A 2 isolated from Bothrops asper snake venom: Role of catalytic activity.
45:335-346.
2005
-
Journal of Pharmaceutical Analysis.
45:171-178.
2005
-
Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A 2 homologues are reduced, but not abolished, by a pH-induced dissociation.
46:291-296.
2005
-
Bothrops asper metalloproteinase BaP1 is inhibited by α 2-macroglobulin and mouse serum and does not induce systemic hemorrhage or coagulopathy.
43:213-217.
2004
-
Effect of a recombinant Lys49PLA2 myotoxin and Lys49PLA 2-derived synthetic peptides from Agkistrodon species on membrane permeability to water.
44:157-159.
2004
-
Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: Understanding the role of metalloproteinases in envenomation.
43:417-424.
2004
-
Membrane independent activation of fibroblast proMMP-2 by snake venom: Novel roles for venom proteinases.
44:749-764.
2004
-
Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops atrox.
44:91-101.
2004
-
A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
42:35-41.
2003
-
Benavides, Yeison.
42:801-808.
2003
-
Enlace al artículo.
42:405-411.
2003
-
Guest editor's foreword.
42:825-826.
2003
-
Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: Comparison between Fab and IgG.
41:237-244.
2003
-
Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
41:851-860.
2003
-
Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene.
42:979-986.
2003
-
Skeletal muscle degeneration induced by venom phospholipases A 2: Insights into the mechanisms of local and systemic myotoxicity.
42:915-931.
2003
-
Snakebite envenomation in Costa Rica: a revision of incidence in the decade 1990–2000.
41:19-22.
2003
-
Hemostatic effects induced by Thalassophryne nattereri fish venom: A model of endothelium-mediated blood flow impairment.
40:1141-1147.
2002
-
Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo.
39:1505-1513.
2001
-
Comparison between IgG and F(ab′)2 polyvalent antivenoms: Neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
39:793-801.
2001
-
Identification of the myotoxic site of the Lys49 phospholipase A2 from Agkistrodon piscivorus piscivorus snake venom: Synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities.
39:1587-1594.
2001
-
Immunochemical properties of the N-terminal helix of myotoxin II, a lysine-49 phospholipase A2 from Bothrops asper snake venom.
39:879-887.
2001
-
Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae).
39:1863-1869.
2001
-
Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom.
39:1173-1181.
2001
-
Horse IgG isotypes and cross-neutralization of two snake antivenoms produced in Brazil and Costa Rica.
38:633-644.
2000
-
Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms.
38:1253-1266.
2000
-
Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper.
38:63-77.
2000
-
A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: Correlation between safety and biochemical characteristics of antivenoms.
37:895-908.
1999
-
Characterization of a basic phospholipase A2-homologue myotoxin isolated from the venom of the snake Bothrops neuwiedii (yarara chica) from Argentina.
37:1735-1746.
1999
-
Characterization of the local tissue damage induced by LHF-II, a metalloproteinase with weak hemorrhagic activity isolated from Lachesis muta muta snake venom.
37:1297-1312.
1999
-
Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro.
37:145-158.
1999
-
Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129.
37:683-687.
1999
-
Neutralization, by a monospecific Bothrops lanceolatus antivenom, of toxic activities induced by homologous and heterologous Bothirops snake venoms.
37:551-557.
1999
-
Structure of a Lys49-Phospholipase A2 homologue isolated from the venom of Bothrops nummifer (jumping viper).
37:371-384.
1999
-
Comparative study of the venoms of three subspecies of Lachesis muta (bushmaster) from Brazil, Colombia and Costa Rica.
36:2021-2027.
1998
-
Inhibition by CaNa2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: Application in horse immunization for antivenom production.
36:321-331.
1998
-
Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom.
36:1529-1538.
1998
-
Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo).
36:1861-1869.
1998
-
A comparison of in vitro methods for assessing the potency of therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus.
35:573-581.
1997
-
Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom.
35:81-90.
1997
-
Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by bothrops asper (terciopelo) snake venom.
35:1627-1637.
1997
-
Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture.
35:865-877.
1997
-
Snakebite mortality in Costa Rica.
35:1639-1643.
1997
-
Universidad de París VII Denis Diderot, Francia.
35:1605-1616.
1997
-
Antibody-mediated neutralization and binding-reversal studies on α-neurotoxins from Micrurus nigrocinctus nigrocinctus (coral snake) venom.
34:369-380.
1996
-
Biochemical and biological characterization of Ecudadorian pitviper venoms (genera Bothriechis, bothriopsis, bothrops and Lachesis).
34:714-717.
1996
-
Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice.
34:567-577.
1996
-
Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of vipera Berus snake venom in mice.
34:1197-1202.
1996
-
Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia).
33:809-815.
1995
-
Evaluacion de la capacidad de cuatro antivenenos comerciales para neutralizar el veneno de la serpiente Bothrops asper (terciopelo) de Costa Rica.
33:1242-1247.
1995
-
Immunological studies on BaH1 and BaP1, two hemorrhagic metalloproteinases from the venom of the snake Bothrops asper.
33:1103-1106.
1995
-
Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo).
33:19-29.
1995
-
Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice.
33:31-39.
1995
-
Phospholipase A2 myotoxins from Bothrops snake venoms.
33:1405-1424.
1995
-
The ability of specific antivenom and low temperature to inhibit the myotoxicity and neuromuscular block induced by Micrurus nigrocinctus venom.
33:679-689.
1995
-
Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro.
32:505-510.
1994
-
Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom.
32:1359-1369.
1994
-
Caprylic acid fractionation of hyperimmune horse plasma: Description of a simple procedure for antivenom production.
32:351-363.
1994
-
Effect of various Viperidae and Crotalidae snake venoms on endothelial cells in vitro.
32:1689-1695.
1994
-
Electrophoretic and immunochemical studies of Micrurus snake venoms.
32:713-723.
1994
-
Immunochemical characterization of Micrurus nigrocinctus nigrocinctus venom with monoclonal and polyclonal antibodies.
32:695-712.
1994
-
Pathological changes induced by BaH1, a hemorrhagic proteinase isolated from Bothrops asper (Terciopelo) snake venom, on mouse capillary blood vessels.
32:977-987.
1994
-
Biological and biochemical activities of Vipera berus (European viper) venom.
31:743-753.
1993
-
Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops Asper (terciopelo) and Bothrops Nummifer (jumping viper).
31:1061-1064.
1993
-
Effects of Bothrops asper (terciopelo) myotoxin III, a basic phospholipase A2, on liposomes and mouse gastrocnemius muscle.
31:217-222.
1993
-
Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper.
31:1137-1150.
1993
-
Turbidity of hyperimmune equine antivenom: The role of phenol and serum lipoproteins.
31:61-66.
1993
-
p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities.
31:1202-1206.
1993
-
Experimental myonecrosis induced by the venoms of South American Micrurus (coral snakes).
30:1299-1302.
1992
-
Investigación y desarrollo en ciencias exactas y naturales.
30:1099-1109.
1992
-
Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies.
30:239-245.
1992
-
Skeletal muscle regeneration after myonecrosis induced by Bothrops asper (terciopelo) venom.
120:169-190.
1992
-
Biochemical and pharmacological similarities between the venoms of newborn Crotalus durissus durissus and adult Crotalus durissus terrificus rattlesnakes.
29:1273-1277.
1991
-
DNase activity in Costa Rican crotaline snake venoms: Quantification of activity and identification of electrophoretic variants.
29:1213-1224.
1991
-
Quantitation by enzyme-immunoassay of antibodies against bothrops myotoxins in four commercially-available antivenoms.
29:695-702.
1991
-
Effect of storage temperature on the stability of the liquid polyvalent antivenom produced in Costa Rica.
28:101-105.
1990
-
Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability.
28:379-384.
1990
-
International Journal of Renewable Energy & Biofuels.
28:75-81.
1990
-
Isolation of basic myotoxins from Bothrops Moojeni and Bothrops Atrox snake venoms.
28:1137-1146.
1990
-
Ontogenetic changes in the venom of the snake Lachesis muta stenophrys (bushmaster) from Costa Rica.
28:419-426.
1990
-
Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom.
27:841-848.
1989
-
Histopathological and biochemical alterations induced by intramuscular injection of Bothrops asper (terciopelo) venom in mice.
27:1085-1093.
1989
-
Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica.
27:735-745.
1989
-
A new method for the detection of phospholipase A2 variants: Identification of isozymes in the venoms of newborn and adult Bothrops asper (terciopelo) snakes.
26:363-371.
1988
-
An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica.
26:411-413.
1988
-
Body distribution of Bothrops asper (terciopelo) snake venom myotoxin and its relationship to pathological changes.
26:403-409.
1988
-
Daniels, Stephen R..
26:675-689.
1988
-
Ability of a polyvalent antivenom to neutralize the venom of Lachesis Muta Melanocephala, a new Costa Rican subspecies of the bushmaster.
25:713-720.
1987
-
Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo).
25:443-449.
1987
-
Detection of proteins antigenically related to Bothrops asper myotoxin in crotaline snake venoms.
25:947-955.
1987
-
Effects of a myotoxic phospholipase A2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum.
25:1244-1248.
1987
-
Immunohistochemical demonstration of the binding of Bothrops asper myotoxin to skeletal muscle sarcolemma.
25:574-577.
1987
-
Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer.
24:885-894.
1986
-
Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom.
23:173-176.
1985
-
Neutralization of hyaluronidase and indirect hemolytic activities of Costa Rican snake venoms by a polyvalent antivenom.
23:1015-1018.
1985
-
Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom.
23:887-893.
1985
-
Estudio ultraestructural de las alteractiones locales inducidas en raton blanco por el veneno de Bothrops picadoi de Costa Rica.
22:301-305.
1984
-
Isolation of a myotoxin from Bothrops asper venom: Partial characterization and action on skeletal muscle.
22:115-128.
1984
-
Estudio comparativo de los venenos de serpiente Cascabel (Crotalus durissus durissus) de ejemplares adultos y recien nacidos.
21:379-384.
1983
-
Local effects induced by coral snake venoms: Evidence of myonecrosis after experimental inoculations of venoms from five species.
21:777-783.
1983
-
Cortés Cabrera, Alvaro.
20:571-579.
1982
-
Estudio de la capacidad ofiofaga y la resistencia de la zopilota (Clelia clelia, Colubridae) de Costa Rica a los venenos de serpiente.
20:936-939.
1982
-
Camacho Villegas, Tanya.
19:493-500.
1981
-
Estudio ultraestructural de la mionecrosis inducida en raton por el veneno de terciopelo (Bothrops asper) de Costa Rica.
19:773-782.
1981
-
Efectos proteolitico, hemorragico y mionecrotico de los venenos de serpientes costarricenses de los generos Bothrops, Crotalus y Lachesis.
18:315-321.
1980
-
Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco.
18:603-610.
1980
Otro